G115-0107 Screening compound: 7-[(3-oxo-1,2,3,4-tetrahydroquinoxalin-1-yl)sulfonyl]-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one

G115-0107 Screening compound: 7-[(3-oxo-1,2,3,4-tetrahydroquinoxalin-1-yl)sulfonyl]-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one
G115-0107 Screening compound: 7-[(3-oxo-1,2,3,4-tetrahydroquinoxalin-1-yl)sulfonyl]-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G115-0107
7-[(3-oxo-1,2,3,4-tetrahydroquinoxalin-1-yl)sulfonyl]-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G115-0107

Molecular Formula

C17H15N3O4S2 (C17 H15 N3 O4 S2)

Compound Name

7-[(3-oxo-1,2,3,4-tetrahydroquinoxalin-1-yl)sulfonyl]-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one

IUPAC name

7-[(3-oxo-1234-tetrahydroquinoxalin-1-yl)sulfonyl]-2345-tetrahydro-15-benzothiazepin-4-one

SMILES

O=C(C1)Nc(cccc2)c2N1S(c(cc1)cc(N2)c1SCCC2=O)(=O)=O

InChI

InChI=1S/C17H15N3O4S2/c21-16-7-8-25-15-6-5-11(9-13(15)19-16)26(23,24)20-10-17(22)18-12-3-1-2-4-14(12)20/h1-6,9H,7-8,10H2,(H,18,22)(H,19,21)

InChI Key

JBDAOUVIZZEJGW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14980761

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

389.46

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.541

Distribution Coefficient, logD

1.541

Water Solubility, LogSw

-2.62

Polar Surface Area

81.376

Acid Dissociation Constant (pKa)

10.71

Base Dissociation Constant (pKb)

-4.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.60

G115-0107 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

BRD4 Targeted Library (4534 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
  • Others
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G115-0107 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G115-0107?
Check Price and Availability of G115-0107, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G115-0107 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G115-0107
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G115-0107
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G115-0107 available by request